Water & Wastewater Engineering
The U.S. Department of Health and Human Services established three new centers to develop and manufacture medical countermeasures, such as vaccines and medicines used to protect health in emergencies, and can transition quickly and cost effectively between products. The centers will aid in bringing new medical countermeasures to the market faster and enhance the nation’s emergency preparedness by providing surge capacity for vaccines and medical countermeasures to chemical and biological events as well as would help to train the biopharmaceutical workforce needed in the future.
The Texas A&M Center for Innovation was founded on an initial $285.6 million public-private partnership with the U.S. Department of Health and Human Services, and focused on emergency preparedness against emerging infectious diseases, including pandemic influenza, and chemical, biological, radiological and nuclear threats. The Center will bring significant economic opportunity to Texas, creating an infrastructure for biopharmaceutical manufacturing, opportunities for workforce development and a path to market for life-saving therapies.
The GarzaEMC team provided full civil engineering services for this project.